A Study of ASP0367 in People With Kidneys That do Not Work Well and in Healthy People

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 21, 2021

Primary Completion Date

November 13, 2022

Study Completion Date

November 22, 2022

Conditions

Renal ImpairmentHealthy Volunteers

Interventions

DRUG

Bocidelpar

Oral

Trial Locations (4)

Advanced Pharma CR, LLC, Miami

Pinnacle Research Group, Anniston

Nucleus Network, Saint Paul

Inland Empire, Rialto

All Listed Sponsors

lead

Astellas Pharma Global Development, Inc.

INDUSTRY

NCT05117294 - A Study of ASP0367 in People With Kidneys That do Not Work Well and in Healthy People | Biotech Hunter | Biotech Hunter